ILT-2 (LIRL ) variants with increased affinity for MHC class I molecules

Details for Australian Patent Application No. 2006351162 (hide)

Owner MediGene Limited

Inventors Li, Yi; Moysey, Ruth Karen; Jakobsen, Bent Karsten

Agent Watermark

Pub. Number AU-A-2006351162

PCT Pub. Number WO2008/062147

Filing date 24 November 2006

Wipo publication date 29 May 2008

International Classifications

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

Event Publications

18 June 2009 PCT application entered the National Phase

  PCT publication WO2008/062147 Priority application(s): WO2008/062147

16 December 2010 Assignment before Grant

  MediGene Limited The application has been assigned to Medigene AG 2007

20 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006351170-Hydrotransistors and integrated hydrologic circuits

2006351139-Method and system for fiber-optic monitoring of spatially distributed components